Martin Shkreli's speech at Harvard disrupted by students protesting AIDs drug price hikes

Address to revered university's Financial Analysts Club interrupted by fire alarm and demonstrations

Thursday 16 February 2017 15:36
Comments
Martin Shkreli
Martin Shkreli

A fire alarm rang out moments before indicted former pharmaceutical executive Martin Shkreli was to speak at Harvard University, briefly delaying an appearance that also was disrupted by student protests.

The former CEO of Turing Pharmaceuticals, who was widely criticised for hiking up the price of a drug used by AIDS and cancer patients to fight parasitic infections, was invited by the Harvard Financial Analysts Club to discuss investing at the Wednesday night event. But a few minutes before it began, someone pulled a fire alarm and police evacuated the building.

When the event did start, protesters kept interrupting Shkreli's presentation, chanting and calling him names before walking out. There were no reports of any violence.

One student group said the appearance “promotes and glorifies murderous financial practices.” It organised a rally and an alternate “teach-in” to discuss pharmaceutical price-gouging while Shkreli's event was taking place.

The Boston Globe reported that most of Shkreli's presentation focused on his experience in hedge fund management and health care. Toward the end of his discussion, he said he had a solution for the high price of prescription drugs.

“Trump should start a drug company,” he said. “I would be proud to help implement this.”

The 33-year-old New York resident is free on $5 million bail pending his federal securities fraud trial in an unrelated case. He has pleaded not guilty. A judge earlier this month approved his request to travel to Massachusetts.

In January, a joint appearance by Shkreli and far-right commentator Milo Yiannopoulos at the University of California, Davis, was cancelled after heated protests erupted.

Shkreli is scheduled to speak at UMass-Boston on Thursday.

AP

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in